5415 related articles for article (PubMed ID: 3525434)
1. Recombinant human tumor necrosis factor--II. Antitumor effect on murine and human tumors transplanted in mice.
Sohmura Y; Nakata K; Yoshida H; Kashimoto S; Matsui Y; Furuichi H
Int J Immunopharmacol; 1986; 8(3):357-68. PubMed ID: 3525434
[TBL] [Abstract][Full Text] [Related]
2. Antitumor activity of murine tumor necrosis factor (TNF) against transplanted murine tumors and heterotransplanted human tumors in nude mice.
Haranaka K; Satomi N; Sakurai A
Int J Cancer; 1984 Aug; 34(2):263-7. PubMed ID: 6469400
[TBL] [Abstract][Full Text] [Related]
3. Antitumor effect of recombinant human interleukin 1 alpha against murine syngeneic tumors.
Nakamura S; Nakata K; Kashimoto S; Yoshida H; Yamada M
Jpn J Cancer Res; 1986 Aug; 77(8):767-73. PubMed ID: 3093425
[TBL] [Abstract][Full Text] [Related]
4. Recombinant human tumor necrosis factor-alpha: evidence of an indirect mode of antitumor activity.
Manda T; Shimomura K; Mukumoto S; Kobayashi K; Mizota T; Hirai O; Matsumoto S; Oku T; Nishigaki F; Mori J
Cancer Res; 1987 Jul; 47(14):3707-11. PubMed ID: 3594435
[TBL] [Abstract][Full Text] [Related]
5. Antitumor effect of recombinant human tumor necrosis factor on human testicular tumors heterotransplanted in nude mice.
Miki T; Ishiguro S; Sawada M; Kotake T
Eur Urol; 1994; 25(3):242-7. PubMed ID: 8200408
[TBL] [Abstract][Full Text] [Related]
6. Antitumor activity of a novel chimera tumor necrosis factor (TNF-STH) constructed by connecting rTNF-S with thymosin beta 4 against murine syngeneic tumors.
Noguchi K; Inagawa H; Tsuji Y; Morikawa A; Mizuno D; Soma G
J Immunother (1991); 1991 Apr; 10(2):105-11. PubMed ID: 2043590
[TBL] [Abstract][Full Text] [Related]
7. [Antitumor activity of tumor necrosis factor (TNF) in vitro and in vivo].
Haranaka K; Satomi N; Sakurai A
Gan To Kagaku Ryoho; 1984 Jul; 11(7):1387-93. PubMed ID: 6742865
[TBL] [Abstract][Full Text] [Related]
8. [Combined effect of PT-050 (recombinant human TNF) and antitumor drugs on syngeneic murine tumors].
Nakata K; Yoshida H; Kashimoto S; Sohmura Y; Nakamura S; Taguchi T
Gan To Kagaku Ryoho; 1986 Oct; 13(11):3186-93. PubMed ID: 3096217
[TBL] [Abstract][Full Text] [Related]
9. Synergistic effects of combination therapy with human recombinant interleukin-2 and tumor necrosis factor in murine tumor models.
Winkelhake JL; Stampfl S; Zimmerman RJ
Cancer Res; 1987 Aug; 47(15):3948-53. PubMed ID: 3496953
[TBL] [Abstract][Full Text] [Related]
10. Effects of murine tumor necrosis factor on heterotransplanted human tumors.
Helson L; Helson C; Green S
Exp Cell Biol; 1979; 47(1):53-60. PubMed ID: 437245
[TBL] [Abstract][Full Text] [Related]
11. Mode of antitumor action of recombinant human tumor necrosis factor on the sarcoma Meth A transplanted in the mouse.
Miyazaki H; Iida M; Matsunaga Y; Fujii T; Nambu K; Amejima H; Oh-e Y; Furukawa H; Matsui Y; Sohmura Y
Biotherapy; 1988; 1(1):47-57. PubMed ID: 3275291
[TBL] [Abstract][Full Text] [Related]
12. Combination effect of recombinant human interleukin 1 alpha with antitumor drugs on syngeneic tumors in mice.
Nakamura S; Kashimoto S; Kajikawa F; Nakata K
Cancer Res; 1991 Jan; 51(1):215-21. PubMed ID: 1899039
[TBL] [Abstract][Full Text] [Related]
13. Recombinant human tumor necrosis factor--I. Cytotoxic activity in vitro.
Nakano K; Abe S; Sohmura Y
Int J Immunopharmacol; 1986; 8(3):347-55. PubMed ID: 3525433
[TBL] [Abstract][Full Text] [Related]
14. Augmentation of the generation of cytotoxic T lymphocytes against syngeneic tumor cells by recombinant human tumor necrosis factor.
Nakano K; Okugawa K; Furuichi H; Matsui Y; Sohmura Y
Cell Immunol; 1989 Apr; 120(1):154-64. PubMed ID: 2649256
[TBL] [Abstract][Full Text] [Related]
15. Synergistic enhancement of the antitumor activity of recombinant human TNF-alpha by recombinant human IFN-gamma.
Taguchi T; Abe S; Nakano K; Matsui Y; Sohmura Y
Cancer Detect Prev; 1988; 12(1-6):105-14. PubMed ID: 3141050
[TBL] [Abstract][Full Text] [Related]
16. Augmented antitumor effect of recombinant human interleukin-1 alpha by indomethacin.
Nakata K; Kashimoto S; Yoshida H; Oku T; Nakamura S
Cancer Res; 1988 Feb; 48(3):584-8. PubMed ID: 3257168
[TBL] [Abstract][Full Text] [Related]
17. Human tumor necrosis factor-alpha mutant RGD-V29 (F4614) shows potent antitumor activity and reduced toxicity against human tumor xenografted nude mice.
Kuroda K; Miyata K; Fujita F; Koike M; Fujita M; Nomura M; Nakagawa S; Tsutsumi Y; Kawagoe T; Mitsuishi Y; Mayumi T
Cancer Lett; 2000 Oct; 159(1):33-41. PubMed ID: 10974403
[TBL] [Abstract][Full Text] [Related]
18. Antitumor activity of recombinant human tumor necrosis factor in combination with hyperthermia against heterotransplanted human prostatic carcinoma and its lymph node metastasis in nude mice.
Hachiya T; Okada K; Sakurai A; Satomi N; Haranaka K
Mol Biother; 1992 Mar; 4(1):34-9. PubMed ID: 1627271
[TBL] [Abstract][Full Text] [Related]
19. Antitumor effects of recombinant human tumor necrosis factor against human tumor xenografts transplanted into nude mice.
Nosoh Y; Toge T; Nishiyama M; Yamaguchi M; Hirabayashi N; Niimoto M; Hattori T
Jpn J Surg; 1987 Jan; 17(1):51-4. PubMed ID: 3573444
[TBL] [Abstract][Full Text] [Related]
20. Broad antitumor and antiangiogenic activities of AG3340, a potent and selective MMP inhibitor undergoing advanced oncology clinical trials.
Shalinsky DR; Brekken J; Zou H; McDermott CD; Forsyth P; Edwards D; Margosiak S; Bender S; Truitt G; Wood A; Varki NM; Appelt K
Ann N Y Acad Sci; 1999 Jun; 878():236-70. PubMed ID: 10415735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
